Synthesis and characterization of PVP-coated large core iron oxide nanoparticles as an MRI contrast agent
- 18 March 2008
- journal article
- Published by IOP Publishing in Nanotechnology
- Vol. 19 (16), 165101
- https://doi.org/10.1088/0957-4484/19/16/165101
Abstract
The purpose of this study was to synthesize biocompatible polyvinylpyrrolidone (PVP)-coated iron oxide (PVP-IO) nanoparticles and to evaluate their efficacy as a magnetic resonance imaging (MRI) contrast agent. The PVP-IO nanoparticles were synthesized by a thermal decomposition method and characterized by x-ray diffraction (XRD), transmission electron microscopy (TEM), dynamic light scattering (DLS), and a superconducting quantum interface device (SQUID). The core size of the particles is about 8–10 nm and the overall size is around 20–30 nm. The measured r2 (reciprocal of T2 relaxation time) and r2* (reciprocal of T2* relaxation time) are 141.2 and 338.1 (s mM)−1, respectively. The particles are highly soluble and stable in various buffers and in serum. The macrophage uptake of PVP-IO is comparable to that of Feridex as measured by a Prussian blue iron stain and phantom study. The signal intensity of a rabbit liver was effectively reduced after intravenous administration of PVP-IO. Therefore PVP-IO nanoparticles are potentially useful for T2-weighted MR imaging.Keywords
This publication has 13 references indexed in Scilit:
- USPIO‐enhanced MR imaging for visualization of synovial hyperperfusion and detection of synovial macrophages: Preliminary results in an experimental model of antigen‐induced arthritisJournal of Magnetic Resonance Imaging, 2006
- Preparation and magnetic resonance imaging effect of polyvinylpyrrolidone-coated iron oxide nanoparticlesJournal of Biomedical Materials Research Part B: Applied Biomaterials, 2006
- Distinct Role of Macrophages in Different Tumor MicroenvironmentsCancer Research, 2006
- Nanoscale Size Effect of Magnetic Nanocrystals and Their Utilization for Cancer Diagnosis via Magnetic Resonance ImagingJournal of the American Chemical Society, 2005
- Characterization of aqueous dispersions of Fe3O4 nanoparticles and their biomedical applicationsBiomaterials, 2005
- Poly(N-vinylpyrrolidone)-block-poly(d,l-lactide) as a new polymeric solubilizer for hydrophobic anticancer drugs: in vitro and in vivo evaluationJournal of Controlled Release, 2004
- MR Imaging with Ultrasmall Superparamagnetic Iron Oxide Particles in Experimental Soft-Tissue Infections in RatsRadiology, 2002
- T1 effects of a bolus-injectable superparamagnetic iron oxide, SH U 555 A: dependence on field strength and plasma concentration--preliminary clinical experience with dynamic T1-weighted MR imaging.Radiology, 1998
- Clinical results with Resovist: a phase 2 clinical trial.Radiology, 1995
- Superparamagnetic iron oxide: clinical application as a contrast agent for MR imaging of the liver.Radiology, 1988